Ackerman S J, Kephart G M, Francis H, Awadzi K, Gleich G J, Ottesen E A
Department of Medicine, Beth Israel Hospital, Boston, MA 02215.
J Immunol. 1990 May 15;144(10):3961-9.
Onchocerciasis patients treated with diethylcarbamazine often undergo a severe inflammatory response, the Mazzotti reaction. To assess the eosinophil's role in the pathogenesis of the Mazzotti reaction, we obtained serial blood, plasma, and skin biopsy specimens from 21 heavily infected patients and 3 endemic controls, both before and during therapy with diethylcarbamazine. Samples were analyzed for blood eosinophils, plasma levels of eosinophil granule major basic protein (MBP) and eosinophil-derived neurotoxin, eosinophil infiltration and eosinophil and mast cell degranulation in the skin. After the first dose of diethylcarbamazine, blood eosinophils fell from a pre-treatment level of 888 +/- 111 to 203 +/- 42 cells/mm3 at 8 h. This decrease was followed by a marked eosinophilia developing over the remaining 7 days of treatment and 14 days of follow-up. Plasma eosinophil-derived neurotoxin levels increased from 56 +/- 4 ng/ml pretreatment to a peak of 82 +/- 9 ng/ml at 8 h and returned to pretreatment levels by 48 h. Beginning at 12 h, plasma MBP levels increased from 730 +/- 74 ng/ml pretreatment to a peak of 1140 +/- 74 ng/ml after 5 days. Pretreatment skin biopsies stained for MBP by immunofluorescence showed a bright fibrillar pattern in the dermis consistent with chronic eosinophil degranulation; the MBP was localized on elastic tissue fibers. After treatment, skin biopsy specimens showed both the pretreatment fibrillar MBP staining pattern as well as focal eosinophil degranulation. Deposition of MBP around microfilariae in the papillary dermis was visible as early as 1.5 h. The lowest blood eosinophil levels and peak plasma eosinophil-derived neurotoxin levels coincided with the infiltration and degranulation of eosinophils in the skin. Mast cell degranulation in the skin was maximal by the first posttreatment biopsy (1.5 h) coincident with the beginning of eosinophil degranulation. Although the pathogenesis of the Mazzotti reaction is clearly complex, our results indicate that eosinophil degranulation is characteristic of the response and that it occurs with a time course suggestive of a role for the eosinophil in determining the clinical and pathologic manifestations of the reaction.
接受乙胺嗪治疗的盘尾丝虫病患者常出现严重的炎症反应,即马佐蒂反应。为评估嗜酸性粒细胞在马佐蒂反应发病机制中的作用,我们在21例重度感染患者和3例地方性对照者接受乙胺嗪治疗前及治疗期间,获取了系列血液、血浆和皮肤活检标本。对样本进行了血液嗜酸性粒细胞、血浆嗜酸性粒细胞颗粒主要碱性蛋白(MBP)和嗜酸性粒细胞衍生神经毒素水平的分析,以及皮肤中嗜酸性粒细胞浸润、嗜酸性粒细胞和肥大细胞脱颗粒情况的分析。首次服用乙胺嗪后,血液嗜酸性粒细胞在8小时内从治疗前的888±111降至203±42个细胞/mm³。这种下降之后,在治疗的剩余7天和随访的14天内出现了明显的嗜酸性粒细胞增多。血浆嗜酸性粒细胞衍生神经毒素水平从治疗前的56±4 ng/ml升至8小时时的峰值82±9 ng/ml,并在48小时时恢复到治疗前水平。从12小时开始,血浆MBP水平从治疗前的730±74 ng/ml升至5天后的峰值1140±74 ng/ml。治疗前通过免疫荧光对皮肤活检标本进行MBP染色,显示真皮中有明亮的纤维状模式,与慢性嗜酸性粒细胞脱颗粒一致;MBP定位于弹性组织纤维上。治疗后,皮肤活检标本显示出治疗前的纤维状MBP染色模式以及局灶性嗜酸性粒细胞脱颗粒。早在1.5小时就可见乳头真皮中微丝蚴周围有MBP沉积。血液嗜酸性粒细胞的最低水平和血浆嗜酸性粒细胞衍生神经毒素的峰值水平与皮肤中嗜酸性粒细胞的浸润和脱颗粒同时出现。皮肤中的肥大细胞脱颗粒在首次治疗后活检时(1.5小时)达到最大,与嗜酸性粒细胞脱颗粒开始同时出现。虽然马佐蒂反应的发病机制显然很复杂,但我们的结果表明,嗜酸性粒细胞脱颗粒是该反应的特征,且其发生的时间进程提示嗜酸性粒细胞在决定该反应的临床和病理表现中起作用。